drugset / Trial / NCT03929250

Pharmacokinetics of Centella Asiatica in the Elderly

NCT03929250 ↗

Phase 0 Completed 8 enrolled Oregon Health and Science University
RandomizedCrossoverDouble-blindScreening

Summary

This study will measure the oral bioavailability and pharmacokinetics of known bioactive compounds from a standardized Centella asiatica water extract (CAW) product (CAP) in cognitively healthy elders.

Timeline

Start
2019-07-05
Primary completion
2019-11-30
Completion
2024-01-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Centella asiatica water extract Traditional medicine (herbal / TCM) 2 g Oral
Subject Centella asiatica water extract Traditional medicine (herbal / TCM) 4 g Oral

Indications

No indication recorded.